| Clinical Services |
|
| Clinical |
|
| 14C Enabled Drug Development |
|
| Pharmaceutical Sciences |
|
| Good Clinical Practice |
|
| MHRA Accreditation |
|
| Synthesis-to-Clinic |
|
| Clinical Capabilities |
|
| Unique Clinical Platforms |
|
| Phase I/IIa |
|
| Drug Product Optimisation |
|
| Pharmaceutical Sciences |
|
| Flexible Studies |
|
| Scintigraphy |
|
| Regulatory |
|
| PK and Metabolism |
|
| Volunteer Recruitment |
|
| Qualified Persons |
|
| Translational Pharmaceutics |
|
| Clinical Trial Services |
|
| RapidFACT– How does it work? |
|
| Human ADME |
|
| First-in-Human |
|
| Phase I |
|
| RapidFIH |
|
| Microtracer |
|
| Umbrella/flexible protocols |
|
| How do we track the capsule through the GI tract? |
|
| Regulatory Approval |
|
| Pharmacoscintigraphy |
|
| Methods of Radiolabelling |
|
| Regulatory Approval |
|
| Understanding GI anatomy and Physiology |
|
| Biometrics and Reporting |
|
